↓ Skip to main content

Tumor Prevention and Genetics

Overview of attention for book
Cover of 'Tumor Prevention and Genetics'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction
  3. Altmetric Badge
    Chapter 2 Genetic susceptibility, predicting risk and preventing cancer.
  4. Altmetric Badge
    Chapter 3 Novel Approaches to Identify Low-Penetrance Cancer Susceptibility Genes Using Mouse Models
  5. Altmetric Badge
    Chapter 4 Development of novel selective cell ablation in the mammary gland and brain to study cell-cell interactions and chemoprevention.
  6. Altmetric Badge
    Chapter 5 Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs
  7. Altmetric Badge
    Chapter 6 Preclinical Models for Chemoprevention of Colon Cancer
  8. Altmetric Badge
    Chapter 7 New Cancer Biomarkers Deriving from NCI Early Detection Research
  9. Altmetric Badge
    Chapter 8 Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial.
  10. Altmetric Badge
    Chapter 9 Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).
  11. Altmetric Badge
    Chapter 10 HRT opposed to low-dose tamoxifen (HOT study): rationale and design.
  12. Altmetric Badge
    Chapter 11 Is mammography screening for breast cancer really not justifiable?
  13. Altmetric Badge
    Chapter 12 How Reliable Is the Evidence for Screening Mammography?
  14. Altmetric Badge
    Chapter 13 Political Interpretation of Scientific Evidence — Case Study of Breast Cancer Screening Policies Around the World
  15. Altmetric Badge
    Chapter 14 Skin Cancer Chemoprevention: Strategies to Save Our Skin
  16. Altmetric Badge
    Chapter 15 Chemoprevention of Nonmelanoma Skin Cancer: Experience with a Polyphenol from Green Tea
  17. Altmetric Badge
    Chapter 16 Chemoprevention of lung cancer: new directions.
  18. Altmetric Badge
    Chapter 17 Key issues in lung cancer chemoprevention trials of new agents.
  19. Altmetric Badge
    Chapter 18 Prevention of Prostate Cancer
  20. Altmetric Badge
    Chapter 19 Clinical Models for Testing Chemopreventative Agents in Prostate Cancer and Overview of SELCT: The Selenium and Vitamin E Cancer Prevention Trial
  21. Altmetric Badge
    Chapter 20 Problems with Prostate-Specific Antigen Screening: A Critical Review
  22. Altmetric Badge
    Chapter 21 Genetic Predisposition as a Basis for Chemoprevention, Surgical and Other Interventions in Colorectal Cancer
  23. Altmetric Badge
    Chapter 22 Fecal Occult Blood Screening — Trial Evidence, Practice and Beyond
  24. Altmetric Badge
    Chapter 23 Is FOB Screening Really the Answer for Lowering Mortality in Colorectal Cancer?
  25. Altmetric Badge
    Chapter 24 Summary and Conclusions
Attention for Chapter 2: Genetic susceptibility, predicting risk and preventing cancer.
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Genetic susceptibility, predicting risk and preventing cancer.
Chapter number 2
Book title
Tumor Prevention and Genetics
Published in
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2003
DOI 10.1007/978-3-642-55647-0_2
Pubmed ID
Book ISBNs
978-3-64-262892-4, 978-3-64-255647-0
Authors

Pharoah, Paul D P, Paul D. P. Pharoah, Pharoah, Paul D. P.

Abstract

A polygenic approach to disease prevention has become a realistic goal that has arisen from the sequencing of the human genome. Some believe it will be possible to identify individuals as susceptible by their genotype and to prevent disease by targeting interventions to those at risk. However, doubts have been expressed about the magnitude of these genetic effects, and hence the potential to apply them either to individuals or to populations. Published data suggest that the familial aggregation of breast cancer not due to the known high penetrance genes is polygenic, which implies that the distribution of risk in the population is continuous. This model is likely to apply to other common cancers. The utility of a continuous distribution for identifying a high-risk group of the population for targeted preventive intervention depends on the spread of that risk distribution. For breast cancer, the data are compatible with a log-normal distribution of genetic risk in the population which is sufficiently wide to provide useful discrimination of high- and low-risk groups. Assuming all the susceptibility genes could be identified, the half of the population at highest risk would account for 88% of all cases. In contrast, if currently identified risk factors for breast cancer were used to stratify the population, the half of the population at highest risk would account for only 62% of all cases. These results suggest that in the future the construction and use of genetic risk profiles may provide significant improvements in the efficacy of population-based programmes of intervention for cancers and other diseases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 1 13%
Professor 1 13%
Student > Ph. D. Student 1 13%
Researcher 1 13%
Professor > Associate Professor 1 13%
Other 1 13%
Unknown 2 25%
Readers by discipline Count As %
Medicine and Dentistry 3 38%
Agricultural and Biological Sciences 2 25%
Biochemistry, Genetics and Molecular Biology 1 13%
Unknown 2 25%